EIF4E expression in tumors: Its possible role in progression of malignancies

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 59-72

  De Benedetti, Arrigo ^a   Harris, Adrian L ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer progression; EIF4E oncogene; Histologic marker; Survival factor; Tumor vascularization

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLIN D1; INITIATION FACTOR 4E; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; GENE EXPRESSION; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE C MYC; PROTEIN SYNTHESIS; PROTO ONCOGENE; REVIEW; RNA TRANSLATION; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; CYCLIN D1; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; EUKARYOTIC INITIATION FACTOR-4E; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOKINES; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDE INITIATION FACTORS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033044355     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00132-0     Document Type: Review

References (105)

1. J.W.B. Hershey, M.B. Mathews, N. Sonenberg (Eds.), Translational Control, CSH Press, 1996.
2. A. Hinnebush, Mechanism of control of amino acid biosynthesis in Saccharomyces cervisiae, Microb. Rev. 52 (1988) 248-273.
3. C.A. Nathan, P. Carter, L. Liu, B. Li, F. Abreo, A. Tudor, S. Zimmer, A. De Benedetti, Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas, Oncogene 15 (1997) 1087-1095.
4. G. Koch, J.A. Bilello, J. Kruppa, F. Koch, Amplification of translational control by memebrane-mediated events: a pleiotropic effect on cellular and viral genes, Ann. NY Acad. Sci. 339 (1980) 280-306.
5. H.F. Lodish, Model for the regulation of mRNA translation applied to haemoglobin synthesis, Nature 251 (1974) 385-388.
6. R. Baserga, The Biology of Cell Reproduction, Harvard University Press, 1985.
7. R. Baserga, The cell cycle: myths and realities, Cancer Res. 50 (1990) 6769-6771.
8. H. Saito, A.C. Hayday, K. Wiman, W.S. Hayward, S. Tonegawa, Activation of the c-myc gene by translocation: a model for translational control, Proc. Natl. Acad. Sci. USA 80 (1983) 7476-7480.
9. A. Darveau, J. Pelletier, N. Sonenberg, Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5′ untranslated region, Proc. Natl. Acad. Sci. USA 82 (1985) 2315-2319.
10. A. De Benedetti, B. Joshi, J.R. Graff, S.G. Zimmer, CHO cells transformed by the translation factor eIF4E display increased c-myc expression, but require overexpression of Max for tumorigenicity, Mol. Cell. Diff. 2 (1994) 347-371.
11. M. Oskarsson, W.L. McClements, D.G. Blair, J.V. Maizel, G.F. Vande Woude, Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus, Science 207 (1980) 1222-1224.
12. J.D. Marth, R.W. Overell, K.E. Meier, E.G. Krebs, R.M. Perlmutter, Translational activation of the lck proto-oncogene, Nature 332 (1988) 171-173.
13. R. Watson, M. Oskarsson, G.F. Vande Woude, HumanDNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus, Proc. Natl. Acad. Sci. USA 79 (1982) 4078-4082.
14. R.S. Paules, R. Buccione, R.C. Moschel, G.F. Vande Woude, J.J. Eppig, Mouse mos protooncogene product is present and functions during oogenesis, Proc. Natl. Acad. Sci. USA 86 (1989) 5395-5399.
15. B.D. Keiper, R.E. Rhoads, Translational recruitment of maternal mRNAs in response to poly(A) elongation requires initiation factor eIF4G-1, Dev. Biol., in press.
16. M. Kozak, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucleic. Acid. Res. 15 (1989) 8125-8147.
17. M. Kozak, The scanning model for translation: an update, J. Cell Biol. 108 (1989) 229-241.
18. M. Kozak, An analysis of vertebrate mRNA sequences: intimations of translational control, J. Cell Biol. 115 (1991) 887-903.
19. M. Zerial, L. Toschi, R.P. Ryseck, M. Schuermann, R. Mueller, R. Bravo, The product of a novel growth factor activated gene, fosB, interacts with Jun proteins enhancing their DNA binding activity, EMBO J. 8 (1989) 805-813.
20. J.E. Landers, S.L. Cassel, D.L. George, Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein, Cancer Res. 57 (1997) 3562-35688.
21. D.S. Hoover, D.G. Wingett, J. Zhang, R. Reeves, N.S. Magnuson, Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor eIF4E, Cell Growth Diff. 8 (1997) 1371-1380.
22. T. Noma, A.B. Glick, A.G. Geiser, M.A. O'Reilly, J. Miller, A.B. Roberts, M.B. Sporn, Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter, Growth Factors 4 (1991) 247-255.
23. B.A. Arrick, A.L. Lee, R.L. Grendell, R. Derynck, Inhibition of translation of transformaing growth factor-beta 3 mRNA by its 5′ untranslated region, Mol. Cell. Biol. 11 (1991) 4306-4313.
24. H. Prats, M. Kaghad, A.P. Prats, M. Klagsbrun, J.M. Lelias, P. Liazun, P. Chalon, J.P. Tauber, F. Amalric, J.A. Smith, D. Caput, High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons, Proc. Natl. Acad. Sci. USA 86 (1989) 1836-1840.
25. C. Kevil, P. Carter, B. Hu, A. De Benedetti, Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation, Oncogene 11 (1995) 2339-2348.
26. R. Kaspar, L. Gerke, in: Translational Control, CSH Press, 1992, pp. 152.
27. F.C. Nilsson, S. Gammeltoft, J. Christiansen, Translational discrimination of mRNAs coding for human insulin-like growth factor II, J. Biol. Chem. 265 (1990) 13431-13434.
28. C.D. Rao, M. Pech, K.C. Robbins, S.A. Aaroson, The 5′ untranslated sequence of the c-sis/PDGF 2 transcript is a potent translational inhibitor, Mol. Cell. Biol. 8 (1988) 284-292.
29. C. Kevil, A. De Benedetti, K.D. Payne, L.L. Coe, S. Laroux, S. Alexander, Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis, Int. J. Cancer 65 (1996) 785-790.
30. J.M. Manzella, W. Rychlik, R.E. Rhoads, J.W. Hershey, P.J. Blackshear, Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phopsphorylation of eukaryotic initiation factors eIF-4B and eIF4E, J. Biol. Chem. 266 (1991) 2383-2389.
31. L.M. Shantz, A.E. Pegg, Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation, Cancer Res. 54 (1994) 2313-2316.
32. R.J. Fagan, A. Lazaris-Karatzas, N. Sonenberg, R. Rozen, Translational control of ornithine aminotransferase. Modulation by initiation factor eIF4E, J. Biol. Chem. 266 (1991) 16518-16523.
33. J.R. Graff, A. De Benedetti, J.W. Olson, P. Tamez, R.A. Casero, S.G. Zimmer, Translation of ODC mRNA and polyamine transport are suppressed in rastransformed CREF cells by depleting translation initiation factor 4E, BBRC 240 (1997) 15-20.
34. R.L. Kaspar, W. Rychlik, M.W. White, R.E. Rhoads, Simultaneous cytoplasmic redistribution of ribosomal protein L32 mRNA and phopshorylation of eukaryotic initiation factor 4E after mitogenic stimulation of Swiss 3T3 cells, J. Biol. Chem. 265 (1990) 3619-3622.
35. S.D. Levy, W. Avni, N. Hariharan, R.P. Perry, O. Meyuhas, Oligopyrimidine tract at the 5′ end of mammalian ribosomal protein mRNAs is required for their translational control, Proc. Natl. Acad. Sci. USA 88 (1991) 3319-3323.
36. I.B. Rosenwald, A. Karatzas, N. Sonenberg, E.V. Schmidt, Elevated levels of cyclin D1 protein in response to increase expression of eukaryotic initiation factor eIF4E, Mol. Cell. Biol. 13 (1993) 7358-7363.
37. A. Flynn, C.G. Proud, The role of eIF4 in cell proliferation, Cancer Surveys 27 (1996) 293-310.
38. M.E. Greenberg, E.B. Ziff, Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene, Nature 311 (1984) 433-438.
39. M. Mathews (Ed.), Translational Control, CSH press, 1989.
40. H. Trachsel (Ed.), Translation in Eukaryotes, CRC Press, 1991.
41. L.S. Hiremath, N.R. Webb, R.E. Rhoads, Immunological detection of the messenger RNA cap-binding protein, J. Biol. Chem. 260 (1985) 7843-7849.
42. R. Duncan, S.C. Milburn, J.B. Hershey, Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4 suggests a role in translational control, J. Biol. Chem. 262 (1987) 380-388.
43. A. De Benedetti, S. Joshi-Barve, C. Rinker-Schaeffer, R.E. Rhoads, Expression of antisense RNA against initiation factor eIF4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and the p220 component of eIF-4F, Mol. Cell. Biol. 11 (1991) 5435-5445.
44. R.E. Rhoads, Cap recognition and the entry of mRNA into the protein synthesis initiation cycle, TIBS 13 (1988) 52-56.
45. R.E. Thach, Cap recap: the involvment of eIF4E in regulating gene expression, Cell 22 (1992) 177-180.
46. R.E. Rhoads, Protein synthesis, cell growth and oncogenesis, Curr. Opin. Cell Biol. 3 (1991) 1019-1024.
47. R.E. Rhoads, Regulation of eukaryotic protein synthesis by initiation factors, J. Biol. Chem. 266 (1993) 3017-3020.
48. S.J. Morley, Signal transduction mechanisms in the regulation of protein synthesis, Mol. Biol. Rep. 19 (1994) 221-231.
49. N. Sonenberg, Remarks on the mechanism of ribosome binding to eukaryotic mRNAs, Gene Expression 3 (1993) 317-332.
50. J. Pelletier, N. Sonenberg, The involvement of mRNA secondary structure in protein synthesis, Biochem. Cell Biol. 65 (1987) 576-581.
51. A.P. Geballe, D.R. Morris, Initiation codons within 5′-leaders of mRNAs as regulators of translation, TIBS 19 (1994) 150-164.
52. H. Ruan, L.M. Shantz, A.E. Pegg, R. Morris, The upstream open reading frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-responsive translationa control element, J. Biol. Chem. 271 (1996) 29576-29582.
53. A. De Benedetti, R.E. Rhoads, Overexpression of eukaryotic protein synthesis initiation factor eIF4E in Hela cells results in aberrant growth and morphology, Proc. Natl. Acad. Sci. USA 87 (1990) 8212-8216.
54. J.C. Lawrence, R.T. Abraham, PHAS/4E-BPs as regulators of mRNA translation and cell proliferation, TIBS 22 (1997) 345-349.
55. L. McKendrick, V.M. Pain, S.J. Morley, Molecules in focus: translation initiation factor 4E, Int. J. Biochem. Cell Biol. 31 (1999) 31-35.
56. R. Raught, A.C. Gingras, eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol. 31 (1999) 43-57.
57. A.E. Koromilas, A. Lazaris-Karatzas, N. Sonenberg, mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF4E, EMBO J. 11 (1992) 4153-4158.
58. A. Lazaris-Karatzas, K.S. Montine, N. Soneneberg, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature 345 (1990) 544-547.
59. A. Lazaris-Karatzas, N. Sonenberg, The mRNA cap-binding protein, eIF4E cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts, Mol. Cell. Biol. 12 (1992) 1234-1238.
60. C.W. Rinker-Schaeffer, J.R. Graff, A. De Benedetti, S.G. Zimmer, R.E. Rhoads, Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts, Int. J. Cancer 55 (1993) 841-847.
61. J.R. Graff, E.R. Boghaert, A. De Benedetti, D.M. Tudor, S.G. Zimmer, Reduction of translation initiation factor 4E reduces tumor growth, invasion and metastasis of ras-transformed cloned rat embryo fibroblast, Int. J. Cancer 60 (1995) 255-263.
62. R.M. Frederickson, W.E. Mushynski, N. Sonenberg, Phosphorylation of translation factor eIF4E is induced in a ras-dependent manner during nerve growth factor-mediated PC12 cell differentiation, Mol. Cell. Biol. 12 (1992) 1239-1247.
63. R. Aloni, D. Peleg, O. Meyuhas, Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver, Mol. Cell. Biol. 12 (1992) 2203-2212.
64. P.S. Klein, D.A. Melton, Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E, Science 265 (1994) 803-805.
65. S.S. Barve, D.A. Cohen, A. De Benedetti, R.E. Rhoads, A.M. Kaplan, Induction of IL-2 transcription in Th2 cells by upregulation of transcription factors with the protein synthesis initiation factor 4E, J. Immunol. 152 (1994) 1171-1181.
66. L.M. Smith, M. Jaramillo, P.T. Tuazon, Modulation of the mitogenic activity of eukaryotic translation factor-4E by protein kinase C, New Biol. 3 (1991) 601-607.
67. G. Packham, J.L. Cleveland, c-Myc and apoptosis, BBA 1242 (1996) 2792-2800.
68. J. Battey, C. Moulding, R. Taub, W. Murphy, T. Stewart, H. Potter, G. Lenir, P. Leder, The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma, Cell 34 (1983) 779-787.
69. S.R. Hann, M. Dixit, R.C. Sears, L. Sealy, The alternatively initiated c-myc proteins differentially regulate transcription through a noncanonical DNA-binding site, Gene Dev. 8 (1994) 2441-2452.
70. C.A. Nathan, L. Liu, B. Li, I. Nandy, F. Abreo, A. De Benedetti, Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer, Oncogene 15 (1997) 579-584.
71. D. Rousseau, R. Kaspar, I. Rosenwald, L. Gerke, N. Sonenberg, Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 messanger-RNA are increased in cells overexpressing initiation factor 4E, Proc. Natl. Acad. Sci. USA 93 (1996) 1065-1070.
72. D.R. Rousseau, A.C. Gingras, A. Pause, N. Sonenberg, The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth, Oncogene 13 (1996) 2415-2420.
73. D. Gospodarowicz, G. Neufield, L. Schweiger, Fibroblast growth factor: Structural and biological properties, J. Cell. Physiol. 5 (1987) 15-26.
74. A. Wellstein, R. Lupu, G. Zugmaier, Autocrine growth stimulation by secreted K-FGF but not by endogenous basic FGF, Cell Growth Differ. 1 (1990) 63-71.
75. A. Wellstein, M.E. Lippman, Fibroblat growth factor and breast cancer, in: S. Broder (Ed.), Molecular Foundations of Oncology, Williams & Wilkins, Baltimore, MD, 1991, pp. 403-417.
76. J. Folkman, M. Klagsbrun, Angiogenic factors, Science 235 (1987) 442-447.
77. M. Klagsbrun, J. Sasse, R. Sullivan, J.A. Smith, Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor, Proc. Natl. Acad. Sci. USA 83 (1986) 2448-2452.
78. R. Smith, G. Peters, C. Dickson, Multiple RNAs expressed from the int-2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors, EMBO J. 7 (1988) 1013-1022.
79. C. Theillet, X. Le Roy, O. De Lapeyriere, Amplification of FGF-related genes in human tumors: Possible involvment of HST in breast carcinomas, Oncogene 4 (1989) 915-922.
80. S. Vagner, M.C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, A.C. Prats, Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes, Mol. Cell. Biol. 15 (1995) 35-44.
81. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goddel, N. Ferrara, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science 246 (1989) 1306-1309.
82. E. Ikeda, M.G. Achen, G. Breier, W. Risau, Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells, J. Biol. Chem. 270 (1995) 19761-19766.
83. M. Stonely, F.E.M. Paulin, J.P.C. Le Quesne, S.A. Chappell, A.E. Willis, C-myc 5′ untranslated region contains an internal internal ribosome entry segment, Oncogene 16 (1998) 423-428.
84. I. Stein, A. Itin, P. Einat, R. Skaliter, Z. Grossman, E. keshet, Translation of VEGF mRNA by internal ribosome entry: Implications for translation under hypoxia, Mol. Cell. Biol. 18 (1998) 3112-3119.
85. P.S. Carter, A. De Benedetti, Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5′UTR, submitted for publication.
86. Y. Miyagi, A. Sugiyama, A. Asai, T. Okazaki, Y. Kuchino, S. Kerr, Elevated levels of eukaryotic initiation factor eIF-4E mRNA in a broad spectrum of transformed cell lines, Cancer Lett. 91 (1995) 247-252.
87. V. Kerekatte, K. Smiley, B. Hu, A. Smith, F. Gelder, A. De Benedetti, The protooncogene/translation factor eIF-4E - A survey of its expression in breast carcinomas, Int. J. Cancer 64 (1995) 27-31.
88. P.A.E. Scott, K. Smith, R. Poulsom, A. De Benedetti, R. Bicknell, A.L. Harris, Differential expression of vascular endothelial growth factor mRNA versus protein isoforms expression in human breast cancer and relationship to eIF4E, Brit. J. Cancer 77 (1998) 2120-2128.
89. B.D.L. Li, L. Liu, M. Dawson, A. De Benedetti, Overexpression of eukaryotic intitiation factor 4E (eIF4E) in breast carcinoma, Cancer 79 (1997) 2385-2389.
90. B.D.L. Li, J. McDonald, R. Nassar, A. De Benedetti, Clinical outcome in stage 1 to 3 breast carcinomas and eIF4E overexpression, An. Surg. Soc. 227 (1998) 756-762.
91. D.L. Sorells, D. Black, C. Meschonat, R.E. Rhoads, A. De Benedetti, M. Gao, B.J. Williams, B.D.L. Li, Detection of eIF4E gene amplification in breast cancer by competitive PCR, An. Surg. One. 5 (1997) 232-237.
92. N. Brass, D. Heckel, U. Sahlin, M. Pfreundschuh, G. Sybrecht, M. Meese, Translation initiation factor eIF4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma, Human Mol. Genet. 6 (1997) 33-39.
93. S. Franklin, T. Pho, F. Abreo, R. Nassar, A. De Benedetti, F. Stucker, C.A. Nathan, Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers, COSM (1998), in press.
94. J. Williams, A. De Benedetti, T. Acree, T. Veanable, J. Eastham, The effect of eIF4E on VEGF expression and angiogenesis in prostate cancer, AACR special conf. Angiogenesis and Cancer, Orlando, FL, 1998.
95. S. Nagata, Apoptosis by death factor, Cell 88 (1997) 355-365.
96. N. De Wind, M. Dekkler, A. van Rossum, M. van der Valk, H. te Riele, Mouse models for hereditatry nonpyposis colorectal cancer, Cancer Res. 88 (1998) 248-255.
97. V. Polunovski, I.B. Rosenwald, A.T. Tan, J. White, L. Chiang, N. Sonenberg, P.B. Bitterman, Translational control of programmed cells death: eIF4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc, Mol. Cell. Biol. 16 (1996) 6573-6581.
98. N. Soneneberg, A.C. Gingras, The mRNA 5′ cap-binding protein eIF4E and control of cell growth, Curr. Opin. Cell Biol. 10 (1998) 268-275.
99. R.M. Jones, J. Branda, K.A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, E.V. Schmidt, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation Factor 4E) is a target for activation by c-myc, Mol. Cell. Biol. 16 (1996) 4754-4764.
100. M. Gao, W. Rychlik, R.E. Rhoads, Cloning and characterization of human eIF4E genes, J. Biol. Chem. 273 (1998) 4622-4628.
101. B.J. Williams, personal communication.
102. M.L. Cher, G.S. Bova, D.H. Moore, E.J. Small, P.R. Carroll, S.S. Pin, J.I. Epstein, W.B. Isaacs, R.H. Jensen, Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomid hybridization and alleotyping, Cancer Res. 56 (1996) 3091-3102.
103. K.S. Reddy, V. Sulkova, c-myc amplification in a preleukemia patient with trisomy 4 and double minutes: Review of the unique coexistence of these two chromosome abnormalities in acute myelogenous leukemia, Cancer Gen. Cytogen. 95 (1997) 206-209.
104. A. Gradi, H. Imataka, Y.V. Svitkin, E. Rom, B. Raught, S. Morino, N. Sonenberg, A novel functional human eukaryotic transition initiation factor 4G, Mol. Cell. Biol. 18 (1998) 334-342.
105. B. Anthony, P. Carter, A. De Benedetti, Overexpression of the protooncogene-translation factor eIF-4E in breast carcinoma cell lines, Int. J. Cancer 65 (1996) 858-863.